Molecular Design International, Inc.

Molecular Design International, Inc. (MDI) is a privately held biotechnology company, engaged in research and development of innovative therapeutics for the areas of wound management. The company is currently focusing on development of treatments for obesity, diabetes, dermatological conditions, cancer and COPD. The company has developed a strong portfolio of pipeline candidates for these diseases. MDI also offers contract based research and development services comprising of services like drug discovery, custom synthesis, preclinical studies and clinical studies. It has also established partnerships with various pharmaceutical companies for the development of its products. The company is headquartered at Memphis in Tennessee, the US.

Street: 
111 South Highland Street
City: 
Memphis
Postcode: 
38111
Federal State : 
United States
WebSite: 
www.moleculardesign.com
Fax: 
1-901-5228772

Company Index Score

Current Index Score Historical Index Score
  • Molecular Design International, Inc. currently scores 50 % in the index.
  • Molecular Design International, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Molecular Design International, Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets